Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Turns To Insider Ian Read To Lead Into Post-Lipitor Era

This article was originally published in The Tan Sheet

Executive Summary

Pfizer's election of Ian Read as president, CEO and director of the company sets the stage for a management transition at the firm, which has underperformed its peers on several measures in recent years.

You may also be interested in...



Pfizer CEO Read Will Pass The Torch To Bourla In 2019

Chief Operating Officer Albert Bourla will succeed Ian Read as CEO of Pfizer, taking over the top spot at a steady point in the big pharma's evolution. Bourla's near-term challenges will be navigating the loss of Lyrica and the changing US health care dynamics.

People In Brief

Read takes helm of Pfizer’s board; Devereux succeeds Rose as Schwabe CEO; USANA shakes up marketing team; Schiff board adds eBay vet; more People In Brief

People In Brief

Read takes helm of Pfizer’s board; Devereux succeeds Rose as Schwabe CEO; USANA shakes up marketing team; Schiff board adds eBay vet; more People In Brief

Related Content

Topics

UsernamePublicRestriction

Register

ID1132115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel